Wellcome Wolfson Institute for Experimental Medicine

Medicine & Life Sciences

1. Adult Respiratory Distress Syndrome 40%
2. Advanced Glycation End Products 21%
3. Anti-Bacterial Agents 13%
4. Artificial Respiration 12%
5. Asthma 24%
6. Biomarkers 25%
7. Blood Vessels 30%
8. Bronchiectasis 18%
9. Cardiac Myocytes 20%
10. cathepsin S 10%
11. Cell Differentiation 13%
12. Choroidal Neovascularization 11%
13. Chronic Obstructive Pulmonary Disease 21%
14. Clinical Trials 16%
15. Cohort Studies 13%
16. Confidence Intervals 15%
17. Cost-Benefit Analysis 13%
18. Costs and Cost Analysis 10%
19. Cough 26%
20. Critical Care 15%
21. Critical Illness 26%
22. Cystic Fibrosis 60%
23. Cytokines 13%
24. Diabetes Complications 12%
25. Diabetic Retinopathy 60%
26. Endothelial Cells 45%
27. Endothelial Progenitor Cells 13%
28. Endothelium 11%
29. Epithelial Cells 23%
30. Eye 58%
31. Fasciola hepatica 18%
32. Fibrosis 13%
33. Gene Expression 11%
34. Genes 25%
35. Glaucoma 61%
36. Health Care Outcome Assessment 12%
37. Heart Failure 20%
38. In Vitro Techniques 16%
39. Infections 23%
40. Inflammasomes 11%
41. Inflammation 36%
42. Intensive Care Units 15%
43. Intraocular Pressure 21%
44. Klebsiella pneumoniae 11%
45. Lasers 15%
46. Lipopolysaccharides 12%
47. Lung 34%
48. Lung Diseases 13%
49. Macrophages 20%
50. Macular Degeneration 100%
51. Macular Edema 22%
52. Membranes 12%
53. Mesenchymal Stem Cells 15%
54. Messenger RNA 14%
55. MicroRNAs 14%
56. Mortality 13%
57. Mutation 13%
58. Northern Ireland 12%
59. Ocular Vision 16%
60. Open Angle Glaucoma 19%
61. Ophthalmologists 11%
62. Optic Disk 11%
63. Oxidative Stress 13%
64. Peptides 20%
65. Pericytes 12%
66. Pharmaceutical Preparations 12%
67. Phenotype 15%
68. Placebos 22%
69. Polymerase Chain Reaction 11%
70. Population 16%
71. Pre-Eclampsia 11%
72. Proteins 26%
73. Pseudomonas aeruginosa 11%
74. Qatar 13%
75. Randomized Controlled Trials 36%
76. Ranibizumab 12%
77. Receptor for Advanced Glycation End Products 12%
78. Retina 62%
79. Retinal Degeneration 12%
80. Retinal Pigment Epithelium 17%
81. Retinal Pigments 15%
82. Retinal Vessels 32%
83. SARS Virus 25%
84. Smooth Muscle 14%
85. Smooth Muscle Myocytes 21%
86. Sputum 13%
87. Stem Cells 17%
88. Systematic Reviews 38%
89. Therapeutics 36%
90. Trematoda 11%
91. Type 1 Diabetes Mellitus 14%
92. Type 2 Diabetes Mellitus 13%
93. Vascular Endothelial Growth Factor A 30%
94. Visual Acuity 14%
95. Visual Field Tests 13%